Salfredins, new aldose reductase inhibitors produced by Crucibulum sp. RF-3817. I. Fermentation, isolation and structures of salfredins
- J Antibiot (Tokyo). 1995 Jun;48(6):439-46. doi: 10.7164/antibiotics.48.439.
- 1. Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.
New inhibitors of Aldose Reductase, designated salfredins A3, A4, A7, C1, C2, C3 and B11, were isolated from the fermentation broth of Crucibulum sp. RF-3817 by successive purification procedures of solvent extraction, silica gel column chromatographies and reverse-phase HPLC. Their structures were established by spectroscopic methods, including UV, SI-MS and NMR. The structures of salfredins A4 and B11 were confirmed by X-ray crystallographic analysis.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Aldose ReductaseResearch Areas: Metabolic Disease
-
target: Aldose ReductaseResearch Areas: Metabolic Disease
-
target: Aldose ReductaseResearch Areas: Metabolic Disease
-
target: Aldose ReductaseResearch Areas: Metabolic Disease
-
target: Aldose ReductaseResearch Areas: Metabolic Disease